Aflatoxin-induced tumors in mice. 1974

D B Louria, and G Finkel, and J K Smith, and M Buse

UI MeSH Term Description Entries
D007279 Injections, Subcutaneous Forceful administration under the skin of liquid medication, nutrient, or other fluid through a hollow needle piercing the skin. Subcutaneous Injections,Injection, Subcutaneous,Subcutaneous Injection
D007928 Lethal Dose 50 The dose amount of poisonous or toxic substance or dose of ionizing radiation required to kill 50% of the tested population. LD50,Dose 50, Lethal
D007942 Leukemia, Experimental Leukemia induced experimentally in animals by exposure to leukemogenic agents, such as VIRUSES; RADIATION; or by TRANSPLANTATION of leukemic tissues. Experimental Leukemia,Experimental Leukemias,Leukemia Model, Animal,Leukemias, Experimental,Animal Leukemia Model,Animal Leukemia Models,Leukemia Models, Animal
D008297 Male Males
D002642 Chick Embryo The developmental entity of a fertilized chicken egg (ZYGOTE). The developmental process begins about 24 h before the egg is laid at the BLASTODISC, a small whitish spot on the surface of the EGG YOLK. After 21 days of incubation, the embryo is fully developed before hatching. Embryo, Chick,Chick Embryos,Embryos, Chick
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000281 Administration, Intranasal Delivery of medications through the nasal mucosa. Drug Administration, Intranasal,Administration, Intranasal Drug,Administration, Nasal,Intranasal Administration,Intranasal Drug Administration,Administrations, Intranasal,Administrations, Intranasal Drug,Administrations, Nasal,Drug Administrations, Intranasal,Intranasal Administrations,Intranasal Drug Administrations,Nasal Administration,Nasal Administrations
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000336 Aerosols Colloids with a gaseous dispersing phase and either liquid (fog) or solid (smoke) dispersed phase; used in fumigation or in inhalation therapy; may contain propellant agents. Aerosol
D000348 Aflatoxins Furano-furano-benzopyrans that are produced by ASPERGILLUS from STERIGMATOCYSTIN. They are structurally related to COUMARINS and easily oxidized to an epoxide form to become ALKYLATING AGENTS. Members of the group include AFLATOXIN B1; aflatoxin B2, aflatoxin G1, aflatoxin G2; AFLATOXIN M1; and aflatoxin M2. Aflatoxin

Related Publications

D B Louria, and G Finkel, and J K Smith, and M Buse
March 2012, International journal of cancer,
D B Louria, and G Finkel, and J K Smith, and M Buse
November 1968, Cancer research,
D B Louria, and G Finkel, and J K Smith, and M Buse
September 2008, Fertility and sterility,
D B Louria, and G Finkel, and J K Smith, and M Buse
June 1968, Journal of the National Cancer Institute,
D B Louria, and G Finkel, and J K Smith, and M Buse
February 1987, Cancer letters,
D B Louria, and G Finkel, and J K Smith, and M Buse
April 2017, Proceedings of the National Academy of Sciences of the United States of America,
D B Louria, and G Finkel, and J K Smith, and M Buse
August 1996, Carcinogenesis,
D B Louria, and G Finkel, and J K Smith, and M Buse
September 2017, Genome research,
D B Louria, and G Finkel, and J K Smith, and M Buse
January 2008, Acta poloniae pharmaceutica,
D B Louria, and G Finkel, and J K Smith, and M Buse
July 1978, Journal of the National Cancer Institute,
Copied contents to your clipboard!